FDA Agrees on Antidepressant Risks for Youth
33560
The US Food and Drug Administration said on Thursday it &quot;generally supports&quot; an advisory panel&#39;s conclusion this week that antidepressants sometimes raise the risk of suicidal behavior in youth.
227478
The Food and Drug Administration will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
395857
A Food and Drug Administration reexamination of data linking the pediatric use of some antidepressants to increased suicidal tendencies has once again found a connection.
116419
The U.S. Food and Drug Administration plans to update antidepressant labels to reflect studies that suggest a link between the drugs and suicide in youth, according to documents released on Friday.
588559
The Food and Drug Administration is likely to require antidepressants to carry strong, "black box" warnings about links between increased suicidal behavior in children who take the drugs, an agency official said Thursday.
484747
U.S. health officials on Friday ordered the makers of all antidepressants to include tough warnings explaining that the drugs increase the chances of suicidal behavior in some children and teens.
58899
Taking antidepressants appears to raise the risk of suicidal thoughts and behavior in adults younger than 25, U.S. Food and Drug Administration staff said in an analysis released on Tuesday.
482977
The US Food and Drug Administration plans to update antidepressant labels to reflect studies that suggest a link between the drugs and suicide in youths, according to documents released on Friday.
47022
BETHESDA, Md.  - The use of some antidepressant  drugs appears linked to an increase in suicidal behavior in  some children and teen-agers, a U.S. advisory panel concluded  on Tuesday.
43196
BETHESDA, Md.  - A U.S. advisory panel urged  regulators on Tuesday to require a "black box" warning on  antidepressant labels about the increased risk of suicidal  behavior in youth who take the drugs.
186256
Labels that warn about potential suicide risks for young patients taking antidepressants need to be stronger. That&#39;s the word from a Food and Drug Administration advisory panel Tuesday.
256354
SILVER SPRING, Maryland  - Members of a U.S. advisory panel agreed with a Food and Drug Administration analysis that found antidepressant use raises the risk of suicidal thoughts and behavior in adults up to age 25, the panel's chairman said on Wednesday.
209607
WASHINGTON - Antidepressants should come with the nation's strongest warning - in a black box on the label - that they can sometimes spur suicidal behavior in children and teenagers, the government's scientific advisers decided Tuesday.    It's a rare risk, and therefore families need detailed information on how to balance that concern with the need to treat depression, which itself can lead to suicide, cautioned advisers to the Food and Drug Administration...
517689
A Food and Drug Administration advisory panel has recommended putting a &quot;black box&quot; warning on antidepressants to indicate they might raise the risk of suicidal behavior in children and teens.
542300
WASHINGTON - All antidepressants must carry a "black box" warning, the government's strongest safety alert, linking the drugs to increased suicidal thoughts and behavior among children and teens taking them, the Food and Drug Administration said Friday.    Because the warnings are primarily seen by doctors, the agency also is creating an information guide for patients to advise them of the risk...
334738
The U.S. Food and Drug  Administration plans to update antidepressant labels to reflect  studies that suggest a link between the drugs and suicide in  youths, but remains cautious about the strength of such ties,   according to documents released on Friday.
385628
WASHINGTON Sept. 15, 2004 - All drugs used to treat depressed children should carry a &quot;black box&quot; warning of the antidepressants&#39; link to increased suicidal thoughts and actions, says a panel of federal advisers.